Please login to the form below

Not currently logged in
Email:
Password:

Farmaindustria names Antoni Esteve as president

Will hold the position for the next two years

farmaindustria antoni esteveSpain's pharma trade body Farmaindustria has appointed Esteve's Antoni Esteve as its new president.

He will replace Elvira Sanz, president of Pfizer's Spanish operation, fulfilling the organisation's statute of alternating presidency between the head of domestic and foreign companies.

Esteve is president of Isdin, part of the his family's Esteve group that is based in Spain. He acknowledged that a key challenge will be ensuring quality patient access to innovative drugs and treatments at all times.

Esteve added over the next few years he will be “seeking new funding formulas and policies to ensure the sustainability of health systems so that they are compatible with the incorporation of the most advanced therapies.”

The decision was made during the Farmaindustria general assembly, which met in special session in Madrid and was opened by the Spanish minister for health, social services and quality, Ana Mato.

30th October 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics